Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pak Fah Yeow InternationalHKSE:00239 -2.53%80 Interest Coverage is 453.77 as of Dec. 2025, which is 423% above its 10-year median of 86.81. GuruFocus rates HKSE:00239 with a GF Score™ of 80/100 and a GF Value™ of HK$2.17 (Fairly Valued). The stock has 3 warning signs investors should review. Among 686 Drug Manufacturers companies, Pak Fah Yeow International ranks better than 85.13% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Pak Fah Yeow International's
Operating Income
for the
six
months ended in Dec. 2025 was HK$60.8 Mil. Pak Fah Yeow International's Interest Expense for the
six
months ended in Dec. 2025 was HK$-0.1 Mil.
Pak Fah Yeow International's interest coverage for the quarter that ended in Dec. 2025 was 453.77.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Pak Fah Yeow International Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Pak Fah Yeow International's Interest Coverage or its related term are showing as below:
HKSE:00239'
s Interest Coverage Range Over the Past 10 Years
Min: 43.01 Med: 86.81 Max: 232.85
Current: 200.9
HKSE:00239's Interest Coverage is ranked better than 85.13% of 686
companies
in the Drug Manufacturers industry
Industry Median: 12.725
vs HKSE:00239: 200.90
Pak Fah Yeow International (HKSE:00239) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Pak Fah Yeow International Interest Coverage Related Terms
Pak Fah Yeow International Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Pak Fah Yeow International Interest Coverage Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pak Fah Yeow International Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Pak Fah Yeow International's Interest Coverage falls into.
Pak Fah Yeow International Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pak Fah Yeow International (HKSE:00239) has a Interest Coverage of 453.77 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Pak Fah Yeow International and its competitors. This is 423% above median its historical median of 86.81. Over the past decade, Pak Fah Yeow International's Interest Coverage has ranged from 43.01 to 232.85. According to the industry distribution chart, Pak Fah Yeow International ranks #102 out of 686 companies in the Drug Manufacturers industry, placing it in the top 14.9%.
Is Pak Fah Yeow International's Interest Coverage too high?
Pak Fah Yeow International's current Interest Coverage of 453.77 is 423% above median its 10-year median of 86.81. Over the past 10 years, this metric has ranged from a low of 43.01 to a high of 232.85. The Drug Manufacturers industry median Interest Coverage is 12.73. Pak Fah Yeow International's value of 453.77 is 3466% above this industry median. Based on the distribution chart, Pak Fah Yeow International ranks #102 out of 686 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pak Fah Yeow International has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pak Fah Yeow International's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pak Fah Yeow International ranks #102 out of 686 companies for Interest Coverage. This places Pak Fah Yeow International in the top 15% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.73. Pak Fah Yeow International's value of 453.77 is 3466% above this benchmark. Historically, Pak Fah Yeow International's own Interest Coverage has ranged from 43.01 to 232.85 over the past decade. While the company's 10-year median is 86.81 vs. the industry median of 12.73, Pak Fah Yeow International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.73, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pak Fah Yeow International's current Interest Coverage of 453.77 is 3466% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Pak Fah Yeow International and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pak Fah Yeow International's current Interest Coverage is 453.77, which is 423% above median its own 10-year median of 86.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pak Fah Yeow International stock overvalued right now?
Based on GuruFocus' analysis, Pak Fah Yeow International (HKSE:00239) is currently considered Fairly Valued. The stock's GF Value™ is HK$2.17, compared to a current price of HK$2.32 — trading 6.7% above its estimated fair value. The current Interest Coverage is 453.77, which is 423% above median its 10-year median of 86.81 and 3466% above the Drug Manufacturers industry median of 12.73. Pak Fah Yeow International's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Pak Fah Yeow International (HKSE:00239), the current Interest Coverage is 453.77 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pak Fah Yeow International (HKSE:00239) Overvalued in 2026?
Based on GuruFocus' analysis, Pak Fah Yeow International stock appears to be overvalued.
The current stock price of HK$2.32 is trading 6.7% above its estimated GF Value™ of HK$2.17.
GuruFocus considers Pak Fah Yeow International to be Fairly Valued.
Key valuation signals for HKSE:00239:
Interest Coverage: 453.77 (423% above median its 10-year median of 86.81)
GF Value™: HK$2.17 vs. price of HK$2.32 (6.7% above fair value)
Industry Position: 3466% above the Drug Manufacturers median (#102 of 686)
No single metric tells the full story. See the HKSE:00239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.The Groups businesses cover Hong Kong, Macau, other regions in the Peoples Republic of China (the PRC or Chinese Mainland), Southeast Asia, North America and the United Kingdom.
80GF Score
Get the complete analysis for HKSE:00239
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00239 has been successfully added to your 
